LT - COMPOSITION COMPRENANT AU MOINS UN SEL PHARMACEUTIQUEMENT ACCEPTABLE D'ELAFIBRANOR SOLUBLE EN MILIEUX AQUEUX PRESENTANT UNE ABSORPTION INTESTINALE AMELIOREE
EN - COMPOSITION COMPRISING AT LEAST ONE WATER-SOLUBLE PHARMACEUTICALLY ACCEPTABLE SALT OF ELAFIBRANOR HAVING IMPROVED INTESTINAL ABSORPTION
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/192 |
(2006.01) |
|
|
A61K 47/18 |
(2017.01) |
|
|
A61K 9/00 |
(2006.01) |
|
|
A61P 1/16 |
(2006.01) |
European patent
| (11) |
Number of the document |
3518916 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
17777046.8 |
|
Date of filing the European patent application |
2017-09-28 |
| (97) |
Date of publication of the European application |
2019-08-07 |
| (45) |
Date of publication and mention of the grant of the patent |
2021-07-07
|
| (46) |
Date of publication of the claims translation |
|
PCT application
| (86) |
Number |
PCT/EP2017/074701 |
|
Date |
2017-09-28 |
PCT application publication
| (87) |
Number |
WO 2018/060372 |
|
Date |
2018-04-05 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
1659438 |
2016-09-30
|
FR |
Inventors
| (72) |
LARUELLE, Claude , FR
BONNAFOUS, Ludovic , FR
|
Grantee
| (73) |
Nashpharm ,
18 avenue Bellevue, 06270 Villeneuve Loubet,
FR
|
Title
| (54) |
COMPOSITION COMPRENANT AU MOINS UN SEL PHARMACEUTIQUEMENT ACCEPTABLE D'ELAFIBRANOR SOLUBLE EN MILIEUX AQUEUX PRESENTANT UNE ABSORPTION INTESTINALE AMELIOREE |
| |
COMPOSITION COMPRISING AT LEAST ONE WATER-SOLUBLE PHARMACEUTICALLY ACCEPTABLE SALT OF ELAFIBRANOR HAVING IMPROVED INTESTINAL ABSORPTION |
